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Effective innate immunity against many microbial
pathogens requires macrophage programs that
upregulate phagocytosis and direct antimicrobial
pathways, two functions generally assumed to be
coordinately regulated. We investigated the regula-
tion of these key functions in human blood-derived
macrophages. Interleukin-10 (IL-10) induced the
phagocytic pathway, including the C-type lectin
CD209 and scavenger receptors, resulting in phago-
cytosis of mycobacteria and oxidized low-density
lipoprotein. IL-15 induced the vitamin D-dependent
antimicrobial pathway and CD209, yet the cells were
less phagocytic. The differential regulation of macro-
phage functional programs was confirmed by anal-
ysis of leprosy lesions: themacrophagephagocytosis
pathway was prominent in the clinically progressive,
multibacillary form of the disease, whereas the
vitaminD-dependentantimicrobial pathwaypredomi-
nated in the self-limited form and in patients under-
going reversal reactions from the multibacillary to
the self-limited form. These data indicate that macro-
phage programs for phagocytosis and antimicrobial
responses are distinct and differentially regulated in
innate immunity to bacterial infections.
INTRODUCTION
Since 1884, when Metchnikoff discovered phagocytes (Metsch-
nikoff, 1884), it has generally been believed that phagocytic cells
both engulf foreign bacteria, parasites, and spores and subse-
quently destroy them. Since this discovery, immunologists
have often linked these two key functions of the innate immune
response, phagocytosis and antimicrobial responses, as being
coregulated for optimal host defense. Following phagocytosis,Cell Hothere are a variety of antimicrobial mechanisms that macro-
phages (MF) utilize to kill pathogens, including the generation
of nitric oxide and superoxide radicals, and in humans the vitamin
D-dependent induction of antimicrobial peptides including cath-
elicidin (Liu et al., 2006). Although a key cytokine of the acquired
immune system, IFN-g, both can reducephagocytosis (Backman
and Guyre, 1994; Konopski et al., 1994) and is known to upregu-
late antimicrobial activity, the mechanisms by which these path-
ways are regulated by the innate immune system are less clear.
In addition to phagocytosis of microbial pathogens, MF also
have a scavenger function to remove extracellular material
including apoptotic cells, cellular debris, and toxic metabolic
products (Mosser and Edwards, 2008). In particular, MF phago-
cytosis of oxidized lipoproteins, such as oxidized low-density
lipoprotein (oxLDL), maintains proper lipid homeostasis within
tissues (Mosser and Edwards, 2008; Greaves and Gordon,
2008) but can lead to foam cell formation in a variety of chronic
infectious and noninfectious inflammatory disorders including
atherosclerosis (Li and Glass, 2002), Whipple disease (Desnues
et al., 2006), xanthomas (Caputo et al., 1986), andmycobacterial
diseases such as tuberculosis (Lucas, 1988; Hunter et al., 2007;
Pagel, 1925; Virchow, 1860; Ridley and Ridley, 1987) and leprosy
(Lucas, 1988; Virchow, 1863; Sakurai and Skinsnes, 1970). The
ability ofMF to endocytosemacromolecules andparticles in their
environment involves several distinct mechanisms including
pinocytosis, receptor-mediated endocytosis, and phagocytosis
(Mosser and Edwards, 2008; Greaves and Gordon, 2008).
The mechanisms that regulate these MF antimicrobial and
phagocytic functions are central to our understanding of innate
immune responses against microbial pathogens. Leprosy
provides an ideal model to study the human innate immune
response tomicrobial infection, since the disease forms a clinical
spectrum in which the pathogen,Mycobacterium leprae, infects
MF, and its fate correlates with the type of immune response
(Yamamura et al., 1991). Although MF infiltration is prominent
in all lesions, MF in the self-healing tuberculoid (T-lep) form are
well-differentiated and rarely contain bacteria, whereas MF in
the disseminated lepromatous (L-lep) form are characterized
by abundant intracellular bacilli and foam cell formation as thest & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc. 343
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(Cruz et al., 2008). Cytokine patterns are also distinct: T-lep
lesions express IFN-g, TNF-a, and IL-15, whereas L-lep lesions
are characterized by the expression of IL-4 and IL-10 (Jullien
et al., 1997; Yamamura et al., 1991). Of these cytokines, IL-15
and IL-10 are both produced by activation of the innate immune
system and are known to regulate MF function but are differen-
tially expressed in leprosy lesions. The ability of IL-15 to induce
MF antimicrobial activity is consistent with the expression of
this cytokine in self-limited T-lep lesions (Jullien et al., 1997);
however, the comparative effects of IL-10 on MF function are
not known. We therefore hypothesized that key cytokines of
the innate immune system, IL-15 and IL-10, trigger distinct MF




To compare the ability of two key innate immune cytokines, IL-10
and IL-15, to trigger MF functional programs (Sozzani et al.,
1998; Krutzik et al., 2005), we cultured human peripheral blood
monocytes with IL-10 or IL-15 for 2 days. Initially we examined
the expression of CD209, a C-type lectin receptor previously
found to be expressed by tissue MF and induced by IL-15 (Krut-
Figure 1. IL-10 Differentiates Monocytes
into CD209+CD163+ MF
(A) Human peripheral monocytes were harvested
at 0 hr or stimulated for 48 hr with IL-10, IL-15, or
media and labeled with specific antibodies.
Results are shown as mean ± SEM (nR 4). **p <
0.001 versus media (t = 48 hr).
(B) IL-10- and IL-15-derived MF were double
labeled with antibodies against CD209 and
specific markers. Results represent mean ± SEM
(n R 4) percent of CD209+ cells positive for the
indicated antibody. *p < 0.05, **p < 0.001 versus
IL-15-derived MF.
zik et al., 2005), and known to be involved
in mediating phagocytosis of M. leprae
(Gringhuis et al., 2007). Both IL-10 and
IL-15 induced monocytes to express
CD209, but not the dendritic cell-specific
marker CD1b (Figure 1A). Maximal
CD209 expression was achieved by 48
hr (data not shown). However, in addition
to CD209, IL-10, but not IL-15, induced
coexpression of CD163, the hemoglobin
scavenger receptor (Kristiansen et al.,
2001) (Figure 1A). In contrast, IL-15
induced greater expression of the costi-
mulatory molecule CD40 (Figure 1B),
while both CD209+ cell populations
expressed MF-specific markers CD14,
CD16 (FcgRIII), and CD64 (FcgRI)
(Figure 1B). Representative histograms
of flow cytometry data can be seen in
Figure S1, available online.We also examined themRNA expres-
sion of additional macrophage markers including NOS2, IL12B,
MRC1, MGLL, and ARG1 (Babu et al., 2009). Expression of
MGLL mRNA was significantly higher in IL-10- versus IL-15-
stimulated monocytes (3.6E10 ± 4.6E9 versus 8.1E9 ± 1.7E9
A.U., p < 0.05, n = 7). Although ARG1 was more strongly ex-
pressed in the IL-10- versus IL-15-stimulated monocytes, the
difference was not significant (1.2E10 ± 5.8E9 versus 6.2E9 ±
2.3E9 A.U., p = 0.26, n = 7). Taken together, these data provide
evidence that IL-10 and IL-15 lead to the differential induction of
MF cell-surface markers.
IL-10, in Comparison to IL-15, Enhances Endocytic
and Phagocytic Activity
Given that IL-10 and IL-15 differentially induce MF cell-surface
phenotypes, we next sought to determine if they induce distinct
immune functions. A primary function for MF is the endocytosis
and phagocytosis of particles to maintain tissue homeostasis
and defend against microbial infection. We first investigated
the ability of monocytes treated for 48 hr with IL-10 versus IL-
15 to regulate pinocytosis according to uptake of, or binding
with, lucifer yellow by flow cytometric analysis of CD209+
MF. Specific uptake was calculated as DMFI = MFIuptake 
MFIbinding. Compared to treatment with IL-15, treatment of
monocytes with IL-10 induced a 10-fold greater uptake of lucifer344 Cell Host & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc.
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method, we measured uptake of fluorescein-labeled dextran,
which is taken up by pinocytosis and receptor-mediated endo-
cytosis via the mannose receptor. Again, compared to treat-
ment with IL-15, treatment of monocytes with IL-10 led to a
5-fold greater uptake of dextran at a range of concentrations
(Figure 2B). Binding alone with lucifer yellow and dextran had
a similar trend as specific uptake but at a much lower level
(Figure S2).
Tomeasure phagocytosis, we evaluated the uptake of fluores-
cently labeled latex beads. Treatment of monocytes with IL-10
as compared to IL-15 resulted in a 2-fold greater level of phago-
cytosis (Figure 2C) and binding (Figure S2) of latex beads. In
summary, IL-10, in comparison to IL-15, induces greater MF
endocytic function.
IL-10 Differentiates Monocytes into Foam Cell MF
In order to maintain tissue homeostasis, a key function of MF is
to scavenge accumulated metabolic products. For example, the
accumulation of oxidized lipids in tissues is regulated by MF
uptake. However, continued phagocytosis of oxidized lipids,
such as oxLDL, can lead to the accumulation of intracellular lipid
leading to foam cell formation (Li and Glass, 2002). Therefore,
to investigate the capacity of IL-10 and IL-15 to induce foam
cell formation, we measured binding and uptake of DiI(1,10-dio-
Figure 2. IL-10-Derived MFHave Enhanced
Endocytic Activity and Develop into Foam
Cell MF
(A–D) Endocytosis assays comparing IL-10- and
IL-15-programmed MF with (A) lucifer yellow, (B)
FITC-labeled dextran, (C) fluorescent latex beads,
or (D) DiI-oxLDL, at indicated concentrations.
Cells assayed for uptake at 37C or binding at
4C, labeled for CD209, data represented as net
intracellular mean florescence intensity (DMFI =
MFIuptake MFIbinding) of indicated dye in CD209+
cells. Data represent the mean (nR 3) ± SEM *p <
0.05, **p < 0.001 versus IL-15-derived MF.
(E) Confocal images of cells cultured and labeled
as in (D). DiI-oxLDL, red; CD209, green; DAPI,
blue.
(F) IL-10- or IL-15-derivedMFwere incubatedwith
unlabeled oxLDL, lipids extracted, and mean ±
SEM (n = 3) of esterified cholesterol shown,
normalized to amount of cell protein.
(G) Uptake of DiI-oxLDL was competed against
excess amounts (303 of DiI-oxLDL) of unlabeled
oxLDL, LDL, or media and analyzed as in
(D). Data represent the mean (n = 3) ± SEM




oxidized low-density lipoprotein (DiI-
oxLDL). IL-10-derived MF were more
efficient in uptake of oxLDL than IL-15,
with an over 18-fold greater MFI (Fig-
ure 2D). Examination by confocal micros-
copy revealed that IL-10-treated cells
contained a greater amount of intracellular DiI-oxLDL than
IL-15-treated cells (Figure 2E). Similar results were observed
with DiI-labeled acetylated LDL (data not shown), another modi-
fied lipoprotein used to evaluate foam cell formation.
A key measure of foam cell formation is the accumulation of
esterified cholesterol (Li and Glass, 2002). Monocytes were
treated with IL-10 versus IL-15 for 48 hr to derive MF, then
incubated with unlabeled oxLDL (25 mg/ml) or media alone
for 24 hr, at which time cellular lipids were extracted and
assayed for cholesterol content. IL-10-treated monocytes incu-
bated with oxLDL contained greater amounts of esterified
cholesterol, a hallmark of foam cell formation, as compared
to IL-10-treated cells with media alone or IL-15-treated mono-
cytes incubated with oxLDL (Figure 2F). Free and total choles-
terol were also elevated in IL-10-treated but not IL-15-treated
cells (Figure S3A).
To confirm that uptake of DiI-oxLDL is specific for the oxidized
form of LDL, we incubated cytokine-derived MF with DiI-LDL
and determined the DiI-LDL uptake was less than 7% of the
uptake seen with DiI-oxLDL (Figure S3B). Furthermore, unla-
beled oxLDL, but not unlabeled LDL, was able to outcompete
labeled DiI-oxLDL uptake by over 56% (Figure 2G). Collectively,
these data demonstrate that IL-10, as compared to IL-15,
programs MF for enhanced uptake of oxLDL resulting in foam
cell formation.Cell Host & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc. 345
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in IL-10-Programmed MF
The uptake of oxLDL leading to foam cell formation is largely
mediated via the scavenger receptors (SRs), a family of recep-
tors defined through binding-modified lipoproteins. The major
scavenger receptors known to bind oxLDL and expressed on
MF include the class A SR, scavenger receptor A (SR-A), and
macrophage receptor with a collagenous structure (MARCO)
and the class B SR, CD36. However, the relative role of each
of these receptors in the pathogenesis of foam cell formation is
unclear, particularly in human cells (Witztum, 2005). As an initial
step to determine the mechanism for the differential oxLDL
uptake by the IL-10- versus the IL-15-derived MF, we compared
the gene expression program of SR by quantitative real-time
PCR (qPCR). IL-10-derived MF had higher expression of SR-A,
CD36, and MARCO than did IL-15-derived MF (Figure 3A).
Furthermore, flow cytometry showed that IL–derived MF were
highly positive for SR-A (81%), CD36 (86%), and MARCO
(71%), while, surprisingly, IL-15-derived MF were largely nega-
tive for expression of any of the SRs (Figure 3B).
To evaluate if SRs are involved in oxLDL uptake, MF pro-
grammed by IL-10 were pretreated with the SR competitive
inhibitors fucoidan and polyinosinic acid (poly-I), then incubated
with DiI-oxLDL. Fucoidan (1–10 mg/mL) and poly-I (1–10 mg/mL)
inhibited DiI-oxLDL uptake by 87% and 88% at their highest
concentrations, respectively (Figure S4). Foam cell formation
has also been reported to also bemediated bymacropinocytosis
(Kruth et al., 2005); however, pretreatment of IL-10-programmed
Figure 3. SR-A and CD36 Mediate oxLDL Uptake in IL-10-Pro-
grammed MF
(A and B) Monocytes were stimulated with IL-10 or IL-15 and scavenger
receptor expression assessed by qPCR (A) after 24 hr or surface protein
expression (B) after 48 hr on CD209+ cells by flow cytometry. Results are
shown as mean ± SEM (nR 3).
(C) Blocking antibodies against SR-A, CD36, MARCO, or isotype were prein-
cubated with IL-10-programmed MF and binding of DiI-oxLDL assayed. All
results are shown as mean ± SEM (n R 3). *p < 0.05, **p < 0.01 *p < 0.005,
**p < 0.001 versus IL-15-treated monocytes.346 Cell Host & Microbe 6, 343–353, October 22, 2009 ª2009 ElseviMF with pinocytosis inhibitor, dimethylamiloride (DMA), showed
no reduction in uptake (Figure S4), indicating that uptake was not
mediated by pinocytosis.
To determine the relative role of the each of the SRs to mediate
binding of oxLDL to IL-10-programmed MF, we utilized available
blocking monoclonal antibodies against SRs including SR-A
(Fukuhara-Takaki et al., 2005), MARCO (Arredouani et al., 2005),
and CD36 (Endemann et al., 1993). IL-10-programmed MF were
pretreated with blocking antibodies or isotype control, and the
percentofcellsbinding toDiI-oxLDLwasmeasured.Blockinganti-
bodies for SR-A and CD36, but not MARCO, were able to inhibit
oxLDL uptake (Figure 3C). Taken together, our data demonstrate
that the IL-10, as compared to IL-15, differentially induces a scav-
enger receptor program inCD209+MF, withgreater expressionof
SR-A and CD36, which mediate efficient binding to oxLDL.
Differential Effect of IL-10 and IL-15 on MF
Phagocytosis of Mycobacteria
An important role of MF in host defense is the phagocytosis of
microbial pathogens to facilitate their clearance. However, in
mycobacterial disease, phagocytosis can contribute to disease
progression if the bacteria persist. To first evaluate the ability of
the cytokine-derived MF to bind mycobacteria, IL-10- and IL-
15-derived adherent MF were incubated at 4C for 2.5 hr with
Mycobacteriumbovis, BacilleCalmette-Gue´rin (BCG) expressing
green fluorescent protein (GFP). Acrossa rangeofmultiplicities of
infection (moi) of BCG, 2%–9%of IL-10-programmedMF bound
BCG, while only 1%–2% of IL-15-programmed MF exhibited
BCG binding (Figure 4A). To evaluate the ability of MF to phago-
cytose and become infected with BCG, the MF were infected
overnight at 37C with BCG-GFP. Similar to the binding experi-
ments, IL-10-programmed MF had a greater capacity to phago-
cytose BCG, with 18%–69%bacteria containing cells, at a range
ofmoi from1 to10, compared to4%–32%for IL-15-programmed
MF (Figure 4B). Confocal laser microscopy revealed that the
overnight incubation with BCG resulted in complete internaliza-
tion of mycobacteria, as BCG were rarely observed bound to
cell surface and at 2.5 moi BCG, IL-10-derived macrophages
contained twice as many bacilli per cell (2.4 ± 0.1 bacteria per
cell) versus IL-15-derived macrophages (1.2 ± 0.1 bacteria per
cell), p < 0.001, n = 4 (Figure 4C). Taken together, our data indi-
cate that the IL-10, as compared to IL-15, is more effective at
inducing a phagocytosis program for uptake of mycobacteria.
IL-10 Programs MF to Coordinately Phagocytose
Mycobacteria and oxLDL
Although foam cell MF are present in several diseases, their
presence is quite typical in disease lesions of leprosy and tuber-
culosis. The foam cell MF in mycobacterial disease, first identi-
fied by Virchow in 1863, contain mycobacteria, such that the
accumulated lipid was thought to be derived from the intracel-
lular bacteria (Virchow, 1863). Recently, we identified that the
lipid within these foam cell MF is derived in part by the accumu-
lation of host-derived oxidized lipids (Cruz et al., 2008). There-
fore, we next compared the ability of the MF to coordinately
take up both mycobacteria and oxLDL. IL-10- versus IL-15-
derived MF were incubated for 4 hr at 37C with BCG-GFP
and DiI-oxLDL, labeled for CD209 and analyzed by flow cytom-
etry as previously described. IL-10-programmed MF hader Inc.
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IL-15-programmed MF (71% versus 6%) (Figure 4D). Further-
more, of the cells that were mycobacteria+, oxLDL+ (double
positive), IL-10-derived MF had a 10-fold higher oxLDL content
than the IL-15-derived MF (Figure 4E).
IL-15 versus IL-10 Differentially Programs the Vitamin D
Antimicrobial Pathway in MF
AkeymechanismbywhichhumanMF kill intracellularmycobacte-
ria is by an IL-15, vitamin D-dependent pathway involving the
conversion of intracellular 25D3 to 1,25D3 by CYP27b1 resulting
in the 1,25D3-dependent induction of the antimicrobial peptide
cathelicidin (Liu et al., 2006, 2007). IL-15, but not IL-10, induces
CYP27b1 after 24 hr stimulation of monocytes (Figure 5A). To
measure the ability of CYP27b1 to convert 25D3, monocytes
were differentiated into MF with IL-10, IL-15, or media alone,
then radiolabeled25D3wasadded for6hrand theamountof radio-
labeled1,25D3assayedbyHPLC. IL-15-programmedMF induced
a7-foldgreater rate of conversion to 1,25D3ascompared to IL-10-
programmedMF ormedia-treated cells (Figure 5B and Figure S5).
Similarly, in IL-15-programmed MF, as compared to IL-10-pro-
grammed MF, 25D3 was sufficient by itself to induce cathelicidin
mRNA (Figure 5C). The VDR was functional in all MF, since in
both IL-15- and IL-10-derived MF 1,25D3 significantly induced
cathelicidinmRNA (Figure 5D). These data suggest that, compara-
tively, IL-15 induces CYP27b1 and the vitamin D-dependent anti-
microbial pathways in MF, while IL-10 induces a scavenger
receptor program, resulting in enhanced phagocytosis (Figure 5E).
CD209+ MF in the Different Forms of Leprosy Lesions
Reflect the Phenotype and Function of the Distinct IL-10
and IL-15 MF Programs
Given the dichotomy in the phenotype and function of the IL-10-
versus IL-15-programmed MF in vitro, we next evaluated the
Figure 4. IL-10-Derived MF Coordinately
Phagocytose Mycobacteria and oxLDL
(A) Binding of BCG-GFP by IL-10- and IL-15-pro-
grammed MF.
(B) Phagocytosis of BCG-GFP by IL-10- and
IL-15-programmed MF. Results are shown as
mean ± SEM (n = 4) percent of CD209+ cells posi-
tive for BCG.
(C) Confocal images of MF cultured as in (B)
(BCG-GFP, green; CD209, red; DAPI, blue).
(D and E) Coordinate uptake of oxLDL and BCG-
GFP by IL-10- or IL-15-programmed MF, (D)
percent of CD209+ cells positive for oxLDL and
BCG. (E) Amount of DiI-oxLDL in CD209+ cells
infected with BCG. Results are shown as mean ±
SEM (n = 3). *p < 0.05, **p < 0.01, *p < 0.005,
**p < 0.001 versus controls.
relevance of these phenotypic and func-
tional subsets in leprosy, providing
a model of human disease in which the
innate and acquired immune response
correlates with the clinical presentation
of the disease. Previous data indicate
that CD209+ MF are equally expressed
in the lesions of the different clinical forms. However, gene
expression profiles of lesions revealed that the phagocytic
gene program, including gene expression of scavenger recep-
tors, was greater in L-lep versus T-lep lesions. L-lep lesions
were found to have higher expression of CD163, SR-A (MSR1),
CD36, MARCO, and other scavenger receptors than T-lep
lesions, correlating with the scavenger receptor gene expression
program found in IL-10-derived MF (Figure 6A). In contrast, the
vitamin D antimicrobial program was predominant in T-lep as
compared to L-lep lesions, with greater expression of
CYP27b1, the enzyme responsible for conversion of 25D3 to
1,25D3 and the VDR. Cathelicidin mRNA expression was below
the limit of detection on the microarray, with 100% of probes
reporting absent. Finally, in patients with reversal reactions, in
which there is a spontaneous conversion from the L-lep to
T-lep form of the disease associated with enhanced immunity
to M. leprae, there was upregulation of the vitamin D antimicro-
bial program and downregulation of the phagocytosis program,
suggesting a plasticity of the responses in vivo depending on the
cytokine environment.
To investigate the phenotype of MF in leprosy lesions, skin
biopsy specimens from the L-lep and T-lep patients were labeled
for the MFmarkers CD209 and CD163. The majority of CD209+
cells present throughout the L-lep granulomas colocalized with
CD163, with 64% of the area positive for CD209 also positive
for CD163, correlating to the IL-10-derived MF phenotype.
Conversely, in the T-lep lesions, CD209+ cells within the granu-
lomas were largely negative for CD163; only 12% of the CD209+
area also expressed CD163, correlating with the IL-15-derived
MF phenotype (Figure 6B). CD209+CD163+ MF were less
frequently present within the dermis of T-lep lesions but outside
the granulomas (data not shown), corresponding to the dermal
tissue macrophage phenotype detected in normal skin (Ochoa
et al., 2008). Again, reversal reactions were associated withCell Host & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc. 347
Cell Host & Microbe
Macrophage Phagocytic and Antimicrobial Programsa change in the CD209+MF population, switching from CD163+
to CD163, with only 13% of the area positive for CD209 colo-
calized with CD163.
A major histological feature of L-lep skin lesions is the pres-
ence of foamy MF containing large amounts of bacilli and lipid,
called ‘‘Virchow’’ cells or ‘‘lepra’’ cells (Virchow, 1860, 1863).
Since the L-lep MF uniquely express CD209 and CD163, we
investigated whether the CD163+ cells found in L-lep skin
lesions corresponded to the Virchow cells.M. leprae was identi-
fied using a monoclonal antibody to its unique phenolic glyco-
lipid, PGL-1. In L-lep lesions, approximately 50% of CD163+
MF were found to contain M. leprae PGL-1, often appearing in
rod-shaped form (Figure 6C), consistent with the presence of
bacilli in MF in L-lep lesions (although we cannot exclude that
the PGL-1 antigen was taken up directly from the serum [Cho
et al., 2001]). Since IL-10-derived MF coordinately take up
both oxLDL andmycobacteria, we next evaluated if theM. leprae
in L-lep MF colocalized with ApoB, the major lipoprotein in
oxLDL (Figure 6D). ApoB and M. leprae colocalized together in
nearly all areas whereM. leprae reactivity was seen, suggesting
the CD163+ MF in L-lep lesions contain both mycobacteria and
oxLDL. In summary, these data provide in vivo evidence that
Figure 5. IL-15 versus IL-10 Differentially
Programs the Vitamin D Antimicrobial
Pathway in MF
(A) CYP27b1 expression was measured by qPCR
in monocytes stimulated with IL-10, IL-15, or
media. Results are shown as mean ± SEM (n = 3)
fold change normalized to media-stimulated cells.
(B) IL-10- or IL-15-derived MF were cultured with
radiolabeled 25D3 and rate of conversion to
1,25D3 measured by HPLC.
(C and D) Expression of cathelicidin mRNA after
culturing IL-10- and IL-15-programmed MF
with 25D3 (C) or 1,25D3 (D) vitamin D. All data
are represented as mean ± SEM (n = 3). *p < 0.05,
**p < 0.001.
(E) Proposedmodel of divergence of phagocytosis
and antimicrobial programs in MF. IL-10 induces
a scavenger receptor program resulting in
enhanced phagocytosis resulting in microbial
persistence, while IL-15 induces the vitamin D-
mediated antimicrobial program resulting in
microbial killing.
CD209+CD163+MF take up bothM. lep-
rae and oxLDL, becoming the foam cells,
and reflective of the IL-10-derived MF
in vitro. Together these data indicate
that the differential expression of MF in
leprosy lesions, as defined by phenotype
and functional programs, correlates with
the outcome to the infection.
DISCUSSION
The modern view of the innate immune
system, like that of Metchnikoff (Metsch-
nikoff, 1884), has traditionally linked the
phagocytic and antimicrobial function of
MF. Our data, however, indicate a divergence of the phagocytic
and antimicrobial programs that corresponds to the outcome of
the host response to the pathogen in human leprosy. Specifi-
cally, the phagocytic program was induced in MF by IL-10 and
evident in the lesions of leprosy patients with the progressive
multibacillary L-lep form of the disease. In contrast, the vitamin
D antimicrobial programwas induced inMF by IL-15 and evident
in the lesions of leprosy patients with the self-healing T-lep form
of the disease. The distinct programs induced by IL-10 versus
IL-15 in MF in vitro are linked to the disease lesions in vivo in
which the expression of IL-10 versus IL-15 correlates with gene
profiles for the phagocytic versus antimicrobial programs. Impor-
tantly, in patients undergoing reversal reactions spontaneously
converting from the L-lep to the T-lep form, there was a switch
from the phagocytic program to the antimicrobial program, link-
ing these pathways to disease outcome. These data establish
that the innate immune response, by selectively inducing IL-10
versus IL-15, differentially programs MF for phagocytic versus
antimicrobial responses, thereby largely determining the out-
come of infection, either to host resistance or to pathogenesis.
What is the possible advantage of the host to having different
programs or limiting the phagocytic activity of the macrophages348 Cell Host & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc.
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on the capacity of macrophages to kill intracellular pathogen. It is
possible that the phagocytic program inMF activated by IL-15 is
limited to prevent the uptake of more microorganisms than can
be killed by a given cell. In a MF model of Trypanosoma cruzi
infection, it was determined that the amount of reactive oxygen
intermediates generated was limiting, and under various condi-
tions, at most one to six parasites could be killed by a given acti-
vated MF (Tanaka et al., 1982); phagocytosis of greater than
6.7 parasites resulted in approximately 20% of MF that allowed
the parasites to survive, replicate, and spread. In this manner,
limiting the phagocytic function of a given MF would optimize
the antimicrobial response against the ingested organisms.
Further limitations are imposed by the pathogen, which can
secrete virulence factors that interfere with antimicrobial path-
ways. For example, mycobacteria secrete glycolipids that in
mouse MF scavenge free oxygen radicals (Chan et al., 1991).
Little is known about the amount of antimicrobial peptides gener-
Figure 6. Dynamics of the Clinical
Response in Leprosy Patients Reflect the
Phenotype and Function of the IL-10- and
IL-15-Derived MF Programs
(A) Gene expression analysis of leprosy skin biop-
sies for vitamin D antimicrobial pathway and
phagocytic program. Each column represents
one donor. n.s., not significant.
(B) Phenotype of MF in human leprosy skin
lesions: L-lep and T-lep skin lesions were labeled
for CD163 (green), CD209 (red), and DAPI (blue).
Scale bar, 40 mm.
(C and D) CD163+ MF in L-lep lesions labeled
for accumulation of oxLDL and mycobacteria
by antibodies against (C) M. leprae or (D) ApoB.
Representative data of at least three patients
were used for each group. Scale bar, 20 mm.
ated in human MF, but it is likely the
amount of antimicrobial peptides gener-
ated by a macrophage is limiting and
that only a defined number of mycobac-
teria can be efficiently killed in a single
cell.
Previous studies indicate that IFN-g
can limit phagocytosis (Konopski et al.,
1994; Backman and Guyre, 1994) but
also induce an antimicrobial response,
providing a mechanism by which the
acquired T cell response regulates these
pathways. The present study provides
insight into mechanisms by which the
innate immune response differentially
regulates the phagocytic versus antimi-
crobial pathways. The IL-15-derived MF
program results in limited phagocytosis
of mycobacteria along with upregulation
of the vitamin D-dependent expression
of the antimicrobial peptide cathelicidin,
allowing the convergence of the phago-
cytic and antimicrobial programs for
optimal host defense against microbial infection. In contrast,
the IL-10-derived MF program involves significantly enhanced
phagocytosis of both oxLDL and mycobacteria, without the
ability to trigger the vitamin D-dependent antimicrobial pathway,
indicating a divergence between the phagocytic and antimicro-
bial programs, providing a favorable intracellular environment
for mycobacterial survival. The coordinate uptake of oxLDL
andmycobacteria may contribute to the pathogenesis of chronic
infection, providing a lipid substrate for energy via the glyoxylate
shunt and synthesis of complex bacterial lipids (Ehrt and
Schnappinger, 2007). Simultaneously, these lipids inhibit the
innate immune response against the bacteria through diminish-
ing TLR-induced antimicrobial activity and skewing the cytokine
balance to induce more IL-10 and less IL-12 cytokine production
(Cruz et al., 2008). The defining receptor of IL-10-derived MF,
CD163, has been shown to mediate the uptake of hemoglobin-
haptoglobin complex (Kristiansen et al., 2001), providing
a source of iron required for mycobacterial survival (RatledgeCell Host & Microbe 6, 343–353, October 22, 2009 ª2009 Elsevier Inc. 349
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(Philippidis et al., 2004). MF similar to those derived by IL-10
were found in the progressive form of leprosy, with the colocal-
ization of the CD209 and CD163 markers, and the presence of
M. leprae, ApoB, and host-derived oxidized phospholipids (Krut-
zik et al., 2005; Cruz et al., 2008).
A physiologic role for IL-10-programmed MF pertains to their
ability to take up various biomolecules relevant for tissue repair,
removal of excess metabolic products, and debris clearance.
IL-10-programmed MF were characterized by high expression
of C-type lectin receptors (CD209, CD206) and scavenger
receptors (CD163, SR-A, CD36, MARCO), implicating a role of
IL-10-derived MF in the uptake of lipids (Terpstra et al., 1998),
lipoproteins (Parthasarathy et al., 1987), apoptotic cells (Platt
et al., 1996), and hemoglobin (Kristiansen et al., 2001), key func-
tions of MF in maintaining tissue homeostasis. Furthermore,
a variety of resident tissue MF, including skin (Ochoa et al.,
2008; Zaba et al., 2007), lung (Soilleux et al., 2002a; Van den
Heuvel et al., 1999), CNS (Fabriek et al., 2005), placenta (Bockle
et al., 2008), and adipose tissue (Zeyda and Stulnig, 2007), share
with IL-10-derived MF the expression of CD209 and CD163, as
well as phagocytic function. The foam cells in atherosclerosis
are similar to IL-10-programmed MF; foam cell MF express
CD209 (Soilleux et al., 2002b), CD163 (Komohara et al., 2006),
and the scavenger receptors SR-A and CD36 (Nakata et al.,
1999). This type of MF is linked to other inflammatory and meta-
bolic diseases in which IL-10 production and foam cell formation
are prominent, including Whipple disease (Desnues et al., 2006)
and xanthomas (Caputo et al., 1986). Although IL-10 may
enhance foam cell formation by induction of a phagocytic
program, other mechanisms may also contribute, such as
enhanced cell survival through decreased apoptosis (Halvorsen
et al., 2005).
The relevance of the MF functional programs to the outcome
in human infectious disease provides a challenge for investiga-
tion, in particular in leprosy and tuberculosis, in which there is
no animal model that fully mimics the human condition. Fortu-
nately, nature has provided us such an opportunity in leprosy,
since it is not a static disease but an extremely dynamic condi-
tion, in which immune changes alter the clinical manifestations
in the form of ‘‘reactional states.’’ One of these reactional states,
so-called ‘‘reversal reactions,’’ provide a window onto the
dynamic immune events associated with mechanisms of immu-
noregulation and immune-mediated tissue injury in human
disease. Reversal reactions are clinically recognized by the
upgrading from the L-lep toward the T-lep pole and clearance
of bacilli from lesions (Waters et al., 1971). Evidence has sug-
gested the pathogenesis of reversal reaction is a naturally occur-
ring delayed-type hypersensitivity (DTH) or type IV immunologic
response to M. leprae, involving influx of CD4+ T cells (Modlin
et al., 1983) and a change in the local cytokine pattern from
type 2 to type 1, including a reduction in IL-10 expression (Godal
et al., 1973; Barnetson et al., 1976; Bjune et al., 1976; Rea and
Taylor, 1977; Yamamura et al., 1992). Here we demonstrate
the dynamic change in MF functional programs, with a switch
from the phagocytic to the vitamin D antimicrobial profile.
Furthermore, reversal reactions involved a change in MF pheno-
type, resulting in the loss of the scavenger receptor CD163
expression on CD209+ cells. These data provide evidence for350 Cell Host & Microbe 6, 343–353, October 22, 2009 ª2009 ElsevMF plasticity in innate immunity, either in the programming of
a given MF or by the influx of new preprogrammed MF, and
indicate that changes in MF functional programs are relevant
to clinical outcome in human infectious disease.
A key question that remains is how the innate immune system
regulates the differential production of IL-15 versus IL-10. TLR
activation induces both IL-15 (Krutzik et al., 2005) and IL-10
(Cruz et al., 2008) production. In addition, immune complexes,
known to be abundant in the L-lep form, trigger the differentiation
of MF which produce IL-10 (Mosser and Edwards, 2008; Tripp
et al., 1995) with the potential to amplify the IL-10-induced MF
program. Nevertheless, our investigation provides insight into
the mechanisms by which the innate immune response, princi-
pally through the production of IL-15 versus IL-10, regulates
the divergent MF functional programs for phagocytosis versus
antimicrobial responses. The differential regulation of these
pathways optimizes antimicrobial efficiency required for host
defense against microbial pathogens, yet the divergence of
these programs can also contribute to the pathogenesis of infec-
tious disease. Therefore, understanding how to modulate these
MF functional programs may be useful to developing new inter-
ventions in human infectious and metabolic diseases in which
macrophage function is central.
EXPERIMENTAL PROCEDURES
Antibodies and Cytokines
Antibodies used for cell-surface markers were as follows: CD1b (OKT6,
Bcd3.1, ATCC), CD14, CD40, and IgG controls (Invitrogen); MARCO (Hycult
Biotechnology); SR-A (R&D Systems); and CD16, CD36, CD64, CD80,
CD86, CD163, CD209, and HLA-DR (BD PharMingen). Recombinant human
IL-10 and IL-15 (R&D Systems) cytokines were used to differentiate mono-
cytes into MF.
Macrophage Differentiation
Human peripheral blood was obtained from healthy donors (UCLA Institutional
Review Board # 92-10-591-31), and adherent monocytes were isolated as
previously described (Liu et al., 2006). Monocytes were then stimulated with
media, IL-10 (10 ng/ml), or IL-15 (200 ng/ml) in 10% FCS in RPMI (Invitrogen)
for 48 hr at 37C.
Cell-Surface Labeling
Surface expression was determined using specific antibodies. A phycoery-
thrin-conjugated secondary antibody (Invitrogen) was used for CD1b, SR-A,
and MARCO. Cells were acquired and analyzed as described (Krutzik et al.,
2005).
Endocytosis and Binding Assays
IL-10- or IL-15-derived MFwere incubated with the following: lucifer yellow or
fluorescein-labeled dextran (Invitrogen) for 1 hr 37C. BCG-GFP (gift from Dr.
Barry Bloom, Harvard) or 1 mm yellow-green-labeled polystyrene latex beads
(Sigma) was incubated with cytokine-derived MF for 16 hr at 37C as previ-
ously described (Krutzik et al., 2005, 2008; Cruz et al., 2008). Binding was
assayed by incubating macrophages with lucifer yellow, FITC-dextran, or
BCG-GFP for 2.5 hr at 4C. Cells were then harvested, labeled with CD209,
and analyzed by flow cytometry. Intracellular uptake was shown as DMFI =
MFIuptake  MFIbinding, unless binding and uptake MFI are shown separately.
BCG-GFP-infected MF were also visualized and quantified via confocal
microscopy as described (Ochoa et al., 2008). Intracellular BCG was quanti-
fied from confocal images of CD209+ cells.
Foam Cell Formation
IL-10- and IL-15-programmed MF were cultured with DiI(1,10-dioctadecyl-
3,3,30,30-tetramethylindocarbocyanine perchlorate)-labeled CuSO4-oxidizedier Inc.
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for uptake. Cells were harvested, labeled with CD209, and analyzed by flow
cytometry and confocal microscopy. Blocking assays were performed by pre-
incubating MF with media, poly-I, fucoidan (Sigma), isotype, SR-A-specific
antibody (Cosmo Bio USA), or CD36-specific antibody (Becton Dickinson)
for 30 min at 4C, then incubated with DiI-oxLDL for 2.5 hr at 4C for binding
and 37C for uptake. For cellular lipid analysis, monocytes, differentiated
with IL-10 or IL-15 for 2 days, were incubated with CuSO4-oxidized low-
density lipoprotein (oxLDL was generously provided by the lipid core of the
Atherosclerosis Research Unit at UCLA) for 24 hr, then washed with cold
PBS and lipids extracted by 3:2 (hexane:isopropanol) as described (Bligh
and Dyer, 1959). Cholesterol was measured by Amplex Red (Invitrogen) and
protein was measured by BCA protein assay (Pierce) according to manufac-
turer protocols.
Real-Time Quantitative PCR
Monocytes were stimulated with IL-10, IL-15, or media for 24 hr or differenti-
ated MF were stimulated with media, 25D3, or 1,25D3 (Biomol) for 24 hr.
RNA was isolated and cDNA synthesized as described (Liu et al., 2006).
Quantitect primers (QIAGEN) were used for determining mRNA expression
of MSR1 (QT00064141), CD36 (QT01674008), MARCO (QT00011977),
CAMP (QT00010458), NOS2 (QT00068740), IL12B (QT00000364), ARG1
(QT00068446), MGLL (QT00039837), and MRC1 (QT00012810). Reactions
used SYBR Green PCR Master Mix (Bio-Rad), normalized to h36B4, and rela-
tive arbitrary units were calculated as described (Liu et al., 2006).
Measurement of Vitamin D Bioconversion by MF
CYP27b1 activity was assessed in IL-10- and IL-15-derived MF as previously
described (Krutzik et al., 2008). Briefly, [3H]-25D3 was added to 106 cells in
200 ml serum-free medium, then incubated for 5 hr at 37C. Vitamin D metab-
olites then extracted and separated by HPLC and elution profiles determined
by UV absorbance at 264 nm. Lauralite 3 software (LabLogic) was used to
quantify peaks of radioactivity corresponding to 25D3 or 1,25D3.
Patients and Clinical Specimens
We classified patients with leprosy according to the criteria of Ridley and
Jopling; all T-lep patients classified as borderline tuberculoid (BT), and all
L-lep patients had lepromatous leprosy (LL). All T-lep and L-lep specimens
were taken at the time of diagnosis before treatment, and reversal reaction
biopsies were upgrading from patients originally diagnosed with borderline
lepromatous leprosy (Krutzik et al., 2005), therefore starting from a different
part of the disease spectrum than the L-lep group. All leprosy patients were
recruited with approval from the Institutional Review Board of the University
of Southern California School of Medicine and the Institutional Ethics
Committee of Oswald Cruz Foundation.
Microarray Data Analysis
Microarrays were using Affymetrix Human U133 Plus 2.0 array comparing 24
leprosy patients (T-lep, n = 10; L-lep, n = 7; RR, n = 7) and analyzed as previ-
ously described (Bleharski et al., 2003). A supervised analysis was performed
for scavenger receptors/phagocytosis genes and vitamin D-mediated antimi-
crobial pathway. Only genes that met differential expression criteria between
groups (p < 0.05; fold change >1.5) were depicted.
Immunofluorescence
Double immunofluorescence on leprosy skin lesions was performed and
examined as described (Krutzik et al., 2005). Briefly, antibodies against
CD163 (AbD Serotec) or ApoB (MB47, gift from Dr. Joseph Witztum UCSD)
were incubated with tissue sections followed by an Alexa Fluor 488 isotype-
specific secondary (Invitrogen). Sections were washed, incubated with mono-
clonal antibodies specific for CD209 orMycobacterium leprae PGL-1 (gift from
Dr. Patrick Brennan) followed by an Alexa Fluor 568 isotype-specific
secondary (Invitrogen). Cells were then preserved with Prolong Gold with
DAPI (Invitrogen). Colocalization analysis was performed by Andor IQ RGB
analysis tool (Andor Technoology, Ireland).
Statistical Analyses
Statistical significance was calculated by paired two-tailed Student’s t test.Cell HoACCESSION NUMBERS
The raw gene expression data analyzed in this study are available online
through the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.
gov/geo/) in series entity GSE17763.
SUPPLEMENTAL DATA
Supplemental Data include five figures andcanbe foundwith this article online at
http://www.cell.com/cell-host-microbe/supplemental/S1931-3128(09)00311-4.
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